• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两个双磷酸化降解结构域通过Fbw7肿瘤抑制因子控制c-Myc的降解。

Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor.

作者信息

Welcker Markus, Wang Baiyun, Rusnac Domniţa-Valeria, Hussaini Yasser, Swanger Jherek, Zheng Ning, Clurman Bruce E

机构信息

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

出版信息

Sci Adv. 2022 Jan 28;8(4):eabl7872. doi: 10.1126/sciadv.abl7872.

DOI:10.1126/sciadv.abl7872
PMID:35089787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8797792/
Abstract

c-Myc (hereafter, Myc) is a cancer driver whose abundance is regulated by the SCF ubiquitin ligase and proteasomal degradation. Fbw7 binds to a phosphorylated Myc degron centered at threonine 58 (T58), and mutations of Fbw7 or T58 impair Myc degradation in cancers. Here, we identify a second Fbw7 phosphodegron at Myc T244 that is required for Myc ubiquitylation and acts in concert with T58 to engage Fbw7. While Ras-dependent Myc serine 62 phosphorylation (pS62) is thought to stabilize Myc by preventing Fbw7 binding, we find instead that pS62 greatly enhances Fbw7 binding and is an integral part of a high-affinity degron. Crystallographic studies revealed that both degrons bind Fbw7 in their diphosphorylated forms and that the T244 degron is recognized via a unique mode involving Fbw7 arginine 689 (R689), a mutational hotspot in cancers. These insights have important implications for Myc-associated tumorigenesis and therapeutic strategies targeting Myc stability.

摘要

c-Myc(以下简称Myc)是一种癌症驱动因子,其丰度受SCF泛素连接酶和蛋白酶体降解调控。Fbw7与以苏氨酸58(T58)为中心的磷酸化Myc降解结构域结合,Fbw7或T58的突变会损害癌症中Myc的降解。在此,我们在Myc的T244位点鉴定出第二个Fbw7磷酸化降解结构域,它是Myc泛素化所必需的,并且与T58协同作用以结合Fbw7。虽然依赖Ras的Myc丝氨酸62磷酸化(pS62)被认为通过阻止Fbw7结合来稳定Myc,但我们发现pS62反而极大地增强了Fbw7的结合,并且是高亲和力降解结构域的一个组成部分。晶体学研究表明,两个降解结构域均以其二磷酸化形式结合Fbw7,并且T244降解结构域通过涉及Fbw7精氨酸689(R689,癌症中的一个突变热点)的独特模式被识别。这些见解对与Myc相关的肿瘤发生以及针对Myc稳定性的治疗策略具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a55e489a2553/sciadv.abl7872-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/fe3b5aceb201/sciadv.abl7872-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a312a50cd46d/sciadv.abl7872-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a57edc0bdc33/sciadv.abl7872-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/390f959466bd/sciadv.abl7872-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/8abfc7f79c2b/sciadv.abl7872-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a55e489a2553/sciadv.abl7872-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/fe3b5aceb201/sciadv.abl7872-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a312a50cd46d/sciadv.abl7872-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a57edc0bdc33/sciadv.abl7872-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/390f959466bd/sciadv.abl7872-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/8abfc7f79c2b/sciadv.abl7872-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f8/8797792/a55e489a2553/sciadv.abl7872-f6.jpg

相似文献

1
Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor.两个双磷酸化降解结构域通过Fbw7肿瘤抑制因子控制c-Myc的降解。
Sci Adv. 2022 Jan 28;8(4):eabl7872. doi: 10.1126/sciadv.abl7872.
2
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.Fbw7肿瘤抑制因子调控糖原合酶激酶3磷酸化依赖性的c-Myc蛋白降解。
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9085-90. doi: 10.1073/pnas.0402770101. Epub 2004 May 18.
3
A Germline Point Mutation in the MYC-FBW7 Phosphodegron Initiates Hematopoietic Malignancies.MYC-FBW7磷酸化降解结构域中的种系点突变引发造血系统恶性肿瘤。
bioRxiv. 2023 Oct 25:2023.10.23.563660. doi: 10.1101/2023.10.23.563660.
4
Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.冬凌草甲素通过触发 Fbw7 介导的 c-Myc 蛋白酶体降解来诱导细胞生长抑制和凋亡。
Mol Cancer Ther. 2012 May;11(5):1155-65. doi: 10.1158/1535-7163.MCT-12-0066. Epub 2012 Mar 2.
5
Fbw7/hCDC4 dimerization regulates its substrate interactions.Fbw7/hCDC4二聚化调节其与底物的相互作用。
Cell Div. 2007 Feb 13;2:7. doi: 10.1186/1747-1028-2-7.
6
Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.腺病毒E1A抑制SCF(Fbw7)泛素连接酶。
J Biol Chem. 2009 Oct 9;284(41):27766-27779. doi: 10.1074/jbc.M109.006809. Epub 2009 Aug 13.
7
Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.Fbw7-Skp1-细胞周期蛋白E复合物的结构:SCF泛素连接酶对多位点磷酸化底物的识别
Mol Cell. 2007 Apr 13;26(1):131-43. doi: 10.1016/j.molcel.2007.02.022.
8
Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.Fbw7促进c-Myb的泛素依赖性降解:GSK3介导的小鼠c-Myb中苏氨酸-572磷酸化的作用。
Oncogene. 2009 Jun 25;28(25):2393-405. doi: 10.1038/onc.2009.111. Epub 2009 May 4.
9
The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.抑癌蛋白 FBW7 和维生素 D 受体是蛋白质周转和转录调节中的相互共因子。
Mol Cancer Res. 2019 Mar;17(3):709-719. doi: 10.1158/1541-7786.MCR-18-0991. Epub 2019 Jan 3.
10
Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.亚型特异性SCF(Fbw7)泛素化介导PGC-1α的差异调节。
J Cell Physiol. 2015 Apr;230(4):842-52. doi: 10.1002/jcp.24812.

引用本文的文献

1
NKD1 enhances colon cancer progression by inhibiting the autophagic degradation of MYC.NKD1通过抑制MYC的自噬降解来促进结肠癌进展。
Cell Death Dis. 2025 Jul 17;16(1):532. doi: 10.1038/s41419-025-07875-8.
2
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth.一种新型肽66CTG可稳定Myc原癌基因蛋白以促进三阴性乳腺癌生长。
Signal Transduct Target Ther. 2025 Jul 9;10(1):217. doi: 10.1038/s41392-025-02298-5.
3
A flexible, high-throughput system for studying live mRNA translation with HiBiT technology.

本文引用的文献

1
Ubiquitylation of MYC couples transcription elongation with double-strand break repair at active promoters.泛素化修饰将转录延伸与活跃启动子处的双链断裂修复偶联。
Mol Cell. 2021 Feb 18;81(4):830-844.e13. doi: 10.1016/j.molcel.2020.12.035. Epub 2021 Jan 15.
2
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.去除癌症中的 Myc:直接抑制 c-Myc 的治疗策略。
Mol Cancer. 2021 Jan 4;20(1):3. doi: 10.1186/s12943-020-01291-6.
3
Recent insight into the role of FBXW7 as a tumor suppressor.近期对 FBXW7 作为肿瘤抑制因子的作用的深入了解。
一种采用HiBiT技术研究活细胞mRNA翻译的灵活、高通量系统。
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf496.
4
Conformational modulation of intrinsically disordered transactivation domains for cancer therapy.用于癌症治疗的内在无序反式激活结构域的构象调节
PNAS Nexus. 2025 May 9;4(5):pgaf152. doi: 10.1093/pnasnexus/pgaf152. eCollection 2025 May.
5
Aurora A binds to the transactivation domain of c-Myc and recognizes the phosphorylated N-terminal degron motif.极光激酶A与c-Myc的反式激活结构域结合,并识别磷酸化的N端降解基序。
Biochem J. 2025 Mar 28;482(8):369-81. doi: 10.1042/BCJ20240726.
6
UM171 glues asymmetric CRL3-HDAC1/2 assembly to degrade CoREST corepressors.UM171 结合不对称的CRL3-HDAC1/2 组装体以降解 CoREST 共抑制因子。
Nature. 2025 Mar;639(8053):232-240. doi: 10.1038/s41586-024-08532-4. Epub 2025 Feb 12.
7
Exploration of degrons and their ability to mediate targeted protein degradation.降解结构域及其介导靶向蛋白质降解能力的探索。
RSC Med Chem. 2025 Jan 1. doi: 10.1039/d4md00787e.
8
Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy.通过溶液核磁共振波谱学探索 N- myc 转录激活结构域的动态和相互作用。
Biochem J. 2024 Nov 6;481(21):1535-1556. doi: 10.1042/BCJ20240248.
9
Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity.镓配合物K6通过提高活性氧水平诱导DNA损伤并增强磷酸酶和张力蛋白同源物活性来抑制结直肠癌。
MedComm (2020). 2024 Jul 24;5(8):e665. doi: 10.1002/mco2.665. eCollection 2024 Aug.
10
Negative Regulation of CPSF6 Suppresses the Warburg Effect and Angiogenesis Leading to Tumor Progression Via c-Myc Signaling Network: Potential Therapeutic Target for Liver Cancer Therapy.抑制 CPSF6 的负调控作用通过 c-Myc 信号网络抑制沃伯格效应和血管生成从而促进肿瘤进展:肝癌治疗的潜在治疗靶点。
Int J Biol Sci. 2024 Jun 17;20(9):3442-3460. doi: 10.7150/ijbs.93462. eCollection 2024.
Semin Cancer Biol. 2020 Dec;67(Pt 2):1-15. doi: 10.1016/j.semcancer.2020.02.017. Epub 2020 Feb 27.
4
Target gene-independent functions of MYC oncoproteins.MYC 癌蛋白的靶基因非依赖性功能。
Nat Rev Mol Cell Biol. 2020 May;21(5):255-267. doi: 10.1038/s41580-020-0215-2. Epub 2020 Feb 18.
5
Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors.发挥最佳 BET 作用:BET 抑制剂治疗在恶性肿瘤中的新兴作用。
Pharmacol Ther. 2020 Apr;208:107479. doi: 10.1016/j.pharmthera.2020.107479. Epub 2020 Jan 11.
6
Non-canonical transcriptional consequences of BET inhibition in cancer.BET 抑制剂在癌症中非经典转录后果。
Pharmacol Res. 2019 Dec;150:104508. doi: 10.1016/j.phrs.2019.104508. Epub 2019 Nov 4.
7
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.小分子 MYC 抑制剂抑制肿瘤生长并增强免疫疗法。
Cancer Cell. 2019 Nov 11;36(5):483-497.e15. doi: 10.1016/j.ccell.2019.10.001. Epub 2019 Oct 31.
8
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.使命必达:癌症中 MYC 治疗靶点的新进展。
BioDrugs. 2019 Oct;33(5):539-553. doi: 10.1007/s40259-019-00370-5.
9
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.MYC 降解筛选在鉴定 KRAS 突变型胰腺癌对 CDK9 抑制剂的敏感性中的应用。
Sci Signal. 2019 Jul 16;12(590):eaav7259. doi: 10.1126/scisignal.aav7259.
10
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism.KRAS 抑制诱导的 MYC 降解被 MEK5-ERK5 补偿机制拮抗。
Cancer Cell. 2018 Nov 12;34(5):807-822.e7. doi: 10.1016/j.ccell.2018.10.001.